Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
19.81
+0.11 (0.53%)
May 16, 2025, 10:07 AM - Market open
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Eton Pharmaceuticals stock ranges from a low of $24 to a high of $33. The average analyst price target of $28.33 forecasts a 43.04% increase in the stock price over the next year.
Price Target: $28.33 (+43.04%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +41.38% | May 14, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | +31.28% | Mar 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $24 | Strong Buy | Reiterates | $21 → $24 | +21.18% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +66.62% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $33 | Strong Buy | Maintains | $17 → $33 | +66.62% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
75.03M
from 39.01M
Increased by 92.33%
Revenue Next Year
115.69M
from 75.03M
Increased by 54.19%
EPS This Year
0.41
from -0.15
EPS Next Year
1.24
from 0.41
Increased by 204.17%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 82.0M | 126.5M | 175.3M | ||
| Avg | 75.0M | 115.7M | 156.0M | ||
| Low | 68.6M | 100.7M | 136.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 110.3% | 68.6% | 51.6% | ||
| Avg | 92.3% | 54.2% | 34.8% | ||
| Low | 75.8% | 34.1% | 17.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.46 | 1.65 | 1.94 | ||
| Avg | 0.41 | 1.24 | 1.68 | ||
| Low | 0.33 | 0.98 | 1.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 304.0% | 56.5% | ||
| Avg | - | 204.2% | 35.6% | ||
| Low | - | 140.2% | 14.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.